The number of people living with dementia worldwide is estimated at 44 million, with
projections indicating this number will double by 2030 and more than triple by 2050 (1) …

Among US adults over age 65, prevalence of de-mentia ranges from 5%–15% with
Alzheimer disease being the most common type of dementia. Because of the growing …

Alzheimer's disease is characterized by progressive cognitive and functional decline. There
are extensive and reciprocal neuronal connections between the epicenters of emotions and …

The neuropsychiatric symptoms of dementia are perhaps the most distressing and difficult-to-
treat features of the disease (Figure 1, page 21). This review addresses the process of …

Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI) and
dementia and are associated with accelerated clinical disease progression. 1 Such …

For the past decade, most published studies 1, 2 but not all of them 3 have shown that
antipsychotic medications are associated with a significant risk of mortality and morbidity in …

Noncognitive neuropsychiatric symptoms (NPS) of dementia (aggression, agitation,
depression, anxiety, delusions, hallucinations, apathy, disinhibition) affect individuals with …

The most recent report of Alzheimer Disease In-ternational, 1 released on World Alzheimer
day 2009, is a grim reminder that the dementia epidemic is now upon us. Worldwide, over …

Dementia has devastating social, economic, and emotional consequences not only for
patients but also for their family caregivers (1, 2). It is a critical public health concern for …

Objective Neuropsychiatric symptoms (NPS) are associated with the risk of incident mild
cognitive impairment (MCI) and dementia. We examined associations between NPS and the …